-
1
المؤلفون: Klaus Warnatz, Kohsuke Imai, Bénédicte Neven, Mette Holm, Ulrich Duffner, B Carpenter, Musa Karakukcu, Hassan Abolhassani, Robert Wynn, Neena Kapoor, Jennifer A. Kanakry, Marina Garcia-Prat, Mariacristina Menconi, Anna Mukhina, Pere Soler-Palacín, Takahiro Tomoda, Claudia Wehr, Diana K. Bayer, Eleonora Gambineri, Gulbu Uzel, Austen Worth, Arunkumar Modi, Mary Slatter, Tania Nicole Masmas, Dimana Dimitrova, Carsten Speckmann, J.J. Bleesing, Shankara Paneesha, Kanchan Rao, Sylwia Kołtan, Carmem Bonfim, Jasmeen Dara, Colin G. Steward, Winnie Ip, Emma C. Morris, Asghar Aghamohammadi, Andrew R. Gennery, Gašper Markelj, Luigi D. Notarangelo, Stephen M. Hughes, Sujal Ghosh, Tsubasa Okano, Ansgar Schulz, Arjan C. Lankester, Stephen Jolles, Ebru Yilmaz, Alexandra Laberko, Maria Elena Maccari, Stephan Ehl, Christopher C. Dvorak, Despina Moshous, Hyoung Jin Kang, Carolina Prando, Zohreh Nademi
المساهمون: Institut Català de la Salut, [Dimitrova D] Experimental Transplantation and Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md. [Nademi Z] Children’s Bone Marrow Transplant Unit, Great North Children’s Hospital, Newcastle upon Tyne, United Kingdom. The Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. [Maccari ME, Ehl S] Department of Pediatric Hematology and Oncology, Center for Pediatrics, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Center for Chronic Immunodeficiency, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [Uzel G] Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. [Tomoda T] Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan. [Garcia-Prat M, Soler-Palacín P] Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Dimitrova, D, Nademi, Z, Maccari, M E, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, A J J, Laberko, A, Mukhina, A, Néven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, J J, Dara, J, Dvorak, C C, Ghosh, S, Kang, H J, Markelj, G, Modi, A, Bayer, D K, Notarangelo, L D, Schulz, A, Garcia-Prat, M, Soler-Palacín, P, Karakükcü, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, T N, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, E C, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, A R, Lankester, A C, Slatter, M & Kanakry, J A 2022, ' International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome ', Journal of Allergy and Clinical Immunology, vol. 149, no. 1, pp. 410-421.e7 . https://doi.org/10.1016/j.jaci.2021.04.036Test
The Journal of allergy and clinical immunology, vol 149, iss 1
Journal of Allergy and Clinical Immunology, 149(1), 410-421. MOSBY-ELSEVIER
The Journal of allergy and clinical immunology
Dimitrova, D, Nademi, Z, Maccari, M E, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, A J J, Laberko, A, Mukhina, A, Néven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, J J, Dara, J, Dvorak, C C, Ghosh, S, Kang, H J, Markelj, G, Modi, A, Bayer, D K, Notarangelo, L D, Schulz, A, Garcia-Prat, M, Soler-Palacín, P, Karakükcü, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, T N, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, E C, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, A R, Lankester, A C, Slatter, M & Kanakry, J A 2022, ' International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome ', The Journal of allergy and clinical immunology, vol. 149, no. 1, pp. 410-421.e7 . https://doi.org/10.1016/j.jaci.2021.04.036Test
Scientiaمصطلحات موضوعية: Graft Rejection, Male, 0301 basic medicine, Oncology, Allergy, lymphoproliferation, mTOR inhibitor, Kaplan-Meier Estimate, Regenerative Medicine, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, hemic and lymphatic diseases, Immunology and Allergy, Cumulative incidence, Child, Otros calificadores::/terapia [Otros calificadores], Immunodeficiency, Cancer, Primary immunodeficiency, Hematopoietic Stem Cell Transplantation, MTOR Inhibitors, Hematology, Middle Aged, Síndromes de deficiència immunitària - Tractament, enfermedades del sistema inmune::síndromes de inmunodeficiencia [ENFERMEDADES], Treatment Outcome, surgical procedures, operative, Child, Preschool, Immune System Diseases::Immunologic Deficiency Syndromes [DISEASES], Female, terapéutica::terapia biológica::tratamientos basados en células y tejidos::trasplante de células::trasplante de células madre::trasplante de células madre hematopoyéticas [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Homologous, Adult, medicine.medical_specialty, activated phosphoinositide 3-kinase delta syndrome, Adolescent, Class I Phosphatidylinositol 3-Kinases, Primary Immunodeficiency Diseases, graft failure, Immunology, serotherapy, Activated PI3K-delta syndrome, Context (language use), Article, Young Adult, 03 medical and health sciences, Rare Diseases, Internal medicine, medicine, Transplantation, Homologous, Humans, Preschool, Retrospective Studies, Aged, Transplantation, allogeneic hematopoietic cell transplantation, Cèl·lules mare hematopoètiques - Trasplantació, business.industry, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Retrospective cohort study, Other subheadings::/therapy [Other subheadings], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, 030104 developmental biology, Graft-versus-host disease, allogeneic hemato-poietic cell transplantation, Avaluació de resultats (Assistència sanitària), Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy::Cell Transplantation::Stem Cell Transplantation::Hematopoietic Stem Cell Transplantation [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], business, 030215 immunology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff24621d0b56e0aaf43e9d30b95d29eTest
https://hdl.handle.net/1887/3277790Test -
2
المؤلفون: Marie Robin, David Michonneau, Nathalie Dhedin, Flore Sicre de Fontbrune, Tereza Coman, Simona Pagliuca, Aliénor Xhaard, Manon Launay, Gérard Socié, Aurélien Sutra Del Galy, Régis Peffault de Latour
المصدر: Bone Marrow Transplantation. 55:86-92
مصطلحات موضوعية: Response rate (survey), Transplantation, medicine.medical_specialty, business.industry, medicine.medical_treatment, Hematology, Hematopoietic stem cell transplantation, Disease, Discovery and development of mTOR inhibitors, Gastroenterology, Tacrolimus, law.invention, 03 medical and health sciences, surgical procedures, operative, 0302 clinical medicine, Randomized controlled trial, law, 030220 oncology & carcinogenesis, Sirolimus, Internal medicine, medicine, TOR Serine-Threonine Kinases, business, 030215 immunology, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6fa617b712e4791ae09f6ebf96fe07f8Test
https://doi.org/10.1038/s41409-019-0633-yTest -
3
المؤلفون: Markus Raderer, Barbara Kiesewetter
المصدر: Memo
مصطلحات موضوعية: Oncology, medicine.medical_specialty, mTOR inhibitor, medicine.medical_treatment, Somatostatin analogues, Peptide receptor radionuclide therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Everolimus, 030212 general & internal medicine, Gastro-enteropancreatic neuroendocrine tumor, Somatostatin Receptor Positive, business.industry, Standard treatment, Hematology, Immunotherapy, Discovery and development of mTOR inhibitors, Short Review, Symptomatic relief, Somatostatin, 030220 oncology & carcinogenesis, Radionuclide therapy, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9149e47116e1884d59fa12ef54a660c6Test
https://doi.org/10.1007/s12254-018-0449-2Test -
4
المؤلفون: Marta Suñer, Mariaconcetta Russo, Saskia Middeldorp, Hessel Peters-Sengers, Frederike J. Bemelman, Aurora Solier-Lopez, Luis Jara-Palomares, Francisco M González-Roncero, Stefano Barco
المساهمون: AII - Inflammatory diseases, Nephrology, Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, Amsterdam Reproduction & Development (AR&D), APH - Aging & Later Life, University of Zurich, Jara-Palomares, Luis
المصدر: Thrombosis research, 195, 100-102. Elsevier Limited
Digital.CSIC. Repositorio Institucional del CSIC
instnameمصطلحات موضوعية: Oncology, medicine.medical_specialty, mTORi, Patient risk, 2720 Hematology, MEDLINE, 610 Medicine & health, Stratification (mathematics), Internal medicine, medicine, Humans, Everolimus, Sirolimus, Hematology, business.industry, 10031 Clinic for Angiology, TOR Serine-Threonine Kinases, Anticoagulants, Venous Thromboembolism, Discovery and development of mTOR inhibitors, Kidney Transplantation, Transplantation, Renal transplant, business, Immunosuppressive Agents, Venous thromboembolism, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7abb92c07db885710aaf29c5625d2c32Test
https://pubmed.ncbi.nlm.nih.gov/32464453Test -
5
المصدر: Pediatric Blood & Cancer. 67
مصطلحات موضوعية: Male, Surgical resection, medicine.medical_specialty, Adolescent, Juvenile nasopharyngeal angiofibroma, medicine.medical_treatment, Angiofibroma, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Embolization, Child, Sirolimus, Antibiotics, Antineoplastic, business.industry, Nasopharyngeal Neoplasms, Hematology, Discovery and development of mTOR inhibitors, Angiofibromas, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Pediatrics, Perinatology and Child Health, Radiology, business, Antiangiogenic drug, 030215 immunology, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e3b27ddbf68b6bf143af6365d1bf51Test
https://doi.org/10.1002/pbc.28162Test -
6
المؤلفون: Jennifer J. Wheler, Apostolia Maria Tsimberidou, Aung Naing, Vivek Subbiah, Siqing Fu, Razelle Kurzrock, Susan Kambrick, Bonnie S. Glisson, Sarina Anne Piha-Paul, Ralph Zinner, Xiaochun Liu, George R. Blumenschein, David S. Hong, Merrill S. Kies
المصدر: Oncotarget
Oncotarget, vol 7, iss 17
Liu, X; Kambrick, S; Fu, S; Naing, A; Subbiah, V; Blumenschein, GR; et al.(2016). Advanced malignancies treated with a combination of the VEGF inhibitor bevacizumab, anti-EGFR antibody cetuximab, and the mTOR inhibitor temsirolimus. ONCOTARGET, 7(17), 23227-23238. doi: 10.18632/oncotarget.7594. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/3xx7q8fsTestمصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Maximum Tolerated Dose, Bevacizumab, Oncology and Carcinogenesis, Cetuximab, and over, bevacizumab, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Internal medicine, temsirolimus, Antineoplastic Combined Chemotherapy Protocols, 80 and over, medicine, Humans, PI3K/AKT/mTOR pathway, Aged, Aged, 80 and over, Sirolimus, Hematology, business.industry, Cancer, solid tumors, Middle Aged, Prognosis, medicine.disease, Discovery and development of mTOR inhibitors, Temsirolimus, Surgery, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, Hypophosphatemia, Research Paper, Follow-Up Studies, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a46d89e727927f9fdb71c1ce8e76522Test
https://doi.org/10.18632/oncotarget.7594Test -
7
المؤلفون: Alvin H. Schmaier, Alona Merkulova, Steven C. Mitchell, Neerman-Arbez Marguerite, Alisa S. Wolberg, Sergei Merkulov
المصدر: Blood. 134:4934-4934
مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Everolimus, Activated Partial Thromboplastin Time measurement, business.industry, Immunology, Pelvic mass, Follicular bronchiolitis, Cell Biology, Hematology, Blood coagulation factors, medicine.disease, Discovery and development of mTOR inhibitors, Biochemistry, medicine, Dysfibrinogenemia, business, Foreign Bodies, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::61160ff8703bedc4ae9adac76c4f4a61Test
https://doi.org/10.1182/blood-2019-131319Test -
8
المؤلفون: A. Ghaisas, R. Patil, Ajay Srinivasan, Darshana Patil, Vineet Datta, Sewanti Limaye, Sachin Apurwa, Raymond L. Page, Ashok K. Vaid, H. Singh, Dadasaheb Akolkar, Tim Crook, Rajan Datar
المصدر: Annals of Oncology. 30:vii32
مصطلحات موضوعية: Drug, Oncology, medicine.medical_specialty, biology, business.industry, media_common.quotation_subject, Hematology, Tumor-Derived, Discovery and development of mTOR inhibitors, Internal medicine, Cancer genetics, medicine, biology.protein, Molecular targets, PTEN, business, Adverse effect, PI3K/AKT/mTOR pathway, media_common
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::42bfe00eadb4a906608d8f6b028e6f39Test
https://doi.org/10.1093/annonc/mdz413.115Test -
9
المؤلفون: Elisa Alonso, Begoña Bermejo, J.M. Cejalvo, S. Moragón, N. Tarazona Llavero, Desamparados Roda, Belen Ortega, S. Zuñiga, Cristina Hernando, M. I. Martínez, Octavio Burgues, Ana Lluch, Valentina Gambardella, P. Rentero, J. Poveda, Soraya Simón, Andrés Cervantes
المصدر: Annals of Oncology. 30:v111
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, business.industry, Hematology, medicine.disease, Discovery and development of mTOR inhibitors, Precision medicine, Genomic screening, Clinical trial, Mutational analysis, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Breast cancer, Oncology, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, business, Triple negative
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6b46ad195e8398e6127b31dfd35316feTest
https://doi.org/10.1093/annonc/mdz242.016Test -
10
المؤلفون: Ghulam Warsi, Lauren Pinter-Brown, Patrick B. Johnston, Kristen White, Radhakrishnan Ramchandren
المصدر: Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-10 (2018)
Experimental Hematology & Oncologyمصطلحات موضوعية: 0301 basic medicine, Oncology, mTOR inhibitors, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Phases of clinical research, Hematopoietic stem cell transplantation, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Refractory, Internal medicine, Clinical endpoint, Medicine, Everolimus, Chemotherapy, lcsh:RC633-647.5, business.industry, Research, lcsh:Diseases of the blood and blood-forming organs, Hematology, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Rash, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Relapsed/refractory, medicine.symptom, business, Hodgkin lymphoma, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d15bf99991b8c85e31c2e1e815fbb14Test
https://doi.org/10.1186/s40164-018-0103-zTest